ClinicalTrials.Veeva

Menu
N

Northwell Health | South Shore University Hospital - Clinical Research Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Apixaban
Polyethylene Glycol
Dofetilide
Coumadin
Flecainide
Propafenone
Sotalol
Rivaroxaban

Parent organization

This site is a part of Northwell Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination

The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commer...

Enrolling
Stroke
Systemic Embolism
Device: Experimental: Laminar Left Atrial Appendage Closure System
Device: Active Comparator: WATCHMAN / Amulet

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maint...

Enrolling
Venous Thromboembolism
Deep Venous Thrombosis
Device: ClotTriever System
Drug: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.

The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...

Active, not recruiting
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, Dofetilide, and Dronedarone

Trial sponsors

Boston Scientific logo
Inari Medical logo
Biosense Webster logo
C
Northwell Health logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems